Glucose

Wilmington, Delaware — A recent legal decision has marked a significant development in the medical technology industry, as Dexcom Inc. has been found to have infringed on a glucose monitor patent held by an Abbott Laboratories unit. This ruling by a Delaware judge resolved a previously undecided matter left by a federal jury in March, which had been unable to reach a verdict on the case. The dispute centers on Dexcom’s use of specific patented technology crucial to glucose monitoring devices that play a vital role in diabetes management. These devices continually measure the glucose … Read more